Trial intelligence / Profile preview

6 vs 12 Months Clopidogrel After Drug-Eluting Stent

DRKS00000132Phase 4Recruiting

Sponsor
Deutsches Herzzentrum München
Start
Jun 2009
Modality
Small Molecules
Countries
13
01

Overview

Phase 4, randomised, double-blind trial of clopidogrel in angina pectoris, myocardial infarction (MI), acute coronary syndrome (ACS) and 1 more (2 arms), sponsored by Deutsches Herzzentrum München. Started Jun 2009; status: recruiting.

02

Drugs

clopidogrel
03

Conditions

angina pectorismyocardial infarction (MI)acute coronary syndrome (ACS)Chronic Coronary Syndrome (CCS)

Beyond the preview

Go deeper on DRKS00000132.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00000132.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call